Renaissance Group’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-179,224
Closed -$5.82M 248
2025
Q4
$5.82M Sell
179,224
-6,748
-4% -$289K 0.23% 115
2025
Q3
$10.5M Buy
185,972
+9,588
+5% +$491K 0.4% 61
2025
Q2
$8.79M Buy
176,384
+87,755
+99% +$3.97M 0.34% 68
2025
Q1
$2.62M Sell
88,629
-123,499
-58% -$4.59M 0.12% 129
2024
Q4
$5.13M Sell
212,128
-11,836
-5% -$293K 0.21% 91
2024
Q3
$4.13M Buy
+223,964
New +$4.01M 0.17% 101

Other funds holding HIMS

Renaissance Group's HIMS Position: Q1 2026 in Review

Renaissance Group sold out of Hims & Hers Health (HIMS) in Q1 2026, closing a stake of 179,224 shares — an estimated $5.82M sold.

Renaissance Group first reported a position in HIMS in Q3 2024 and held it in 6 quarters. The position peaked at $10.5M in Q3 2025. 436 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Renaissance Group reported no remaining Hims & Hers Health position as of Q1 2026 after selling out during the quarter.
  • Renaissance Group sold 179,224 Hims & Hers Health shares in Q1 2026, an estimated $5.82M.
  • Renaissance Group first reported a position in Hims & Hers Health in Q3 2024 and held it in 6 quarters.
  • Renaissance Group's Hims & Hers Health position peaked at $10.5M in Q3 2025.
  • 436 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Renaissance Group's 13F filing for Q1 2026, filed 13 May 2026.